Geopolitical supply chain mapping identifies hidden dependencies across corridors, ports, airports, customs gateways, and carriers that can undermine continuity despite apparent supplier ...

Wilhelm's comments describe a supply chain strategy built around flexibility, balancing inventory positioned close to ...

Rising U.S. prescription spending heightens urgency to identify when to trigger clinical review, discontinue payment, or shift to lower-cost options before avoidable spend accrues. “Subtraction ...

In this week's Pharma Pulse, Cardinal Health expands its at-Home Solutions business with two acquisitions, President Trump lays out a phased tariff schedule for generic drugs, and Novo Nordisk sues ...

Embedding access tools at prescribing reduces manual enrollment, portal switching, and late activation, enabling faster ...

Semmelweis combines frontier LLM reasoning with proprietary clinical grounding using an identity graph of 6+ million verified HCPs, 185+ EHR integrations, and live Clinical Intent Signals. A bounded ...

Medicaid work requirements under the One Big Beautiful Bill Act demand employment/volunteering documentation and clinician attestations, while exemption severity criteria vary by state and may be ...

2026 commercial dynamics are defined by a widening gap between firms with strong order-book visibility and those facing protracted uncertainty, rather than a clean “two halves” cycle. Marketing ...

Claims target comparative ads that juxtapose tirzepatide’s maximum tolerated doses with semaglutide regimens that omit FDA-approved higher strengths, potentially creating a misleading efficacy ...

Amy Niles of the Patient Advocate Foundation revisits her 2026 outlook on prior authorization reform and the Medicare Prescription Payment Plan. Pharmaceutical Commerce continues its H1 Review/H2 ...

In this week's Pharma Pulse, CVS Caremark settles with the FTC over rebates and TrumpRx, Germany more than doubles its drug rebate, and the FDA proposes a registration rule. Welcome to Pharma Pulse, a ...

Cencora's Brent Wilhelm explains why final-mile drug delivery hinges on carrier network visibility, and how AI is helping route around weather-driven disruptions. In part 2 of a 3-part interview with ...